AP26113 is an orally bio available inhibitor of anaplastic lymphoma kinase. Brigatinib (AP26113) is used to treat a certain type of non-small cell lung cancer. Shenzhen Tianyuan Pharmaceutical Technology.Co., Ltd is the leading manufacturer and supplier of lenvatinib intermediate. We are specializing in targeted anticancer drug research and devoted to researching, manufacturing, and marketing medical raw materials.
Please read the originial post here: https://www.tianpharm.com/products/ap26113-intermediates
